LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 51.55 | 771.67 | 1479 | 6829 | 0.2166 | 0.2297 | MN20160304_L01 | L13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 53.77 | 771.67 | 1405 | 7256 | 0.1936 | 0.2036 | MN20160304_L01 | L11 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 53.77 | 771.67 | 1475 | 7256 | 0.2033 | 0.2219 | MN20160304_L01 | L13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 55.99 | 771.67 | 1419 | 7690 | 0.1845 | 0.2016 | MN20160304_L01 | L11 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 55.99 | 771.67 | 1463 | 7690 | 0.1902 | 0.2127 | MN20160304_L01 | L13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 58.21 | 771.67 | 1384 | 8085 | 0.1712 | 0.1881 | MN20160304_L01 | L11 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 58.21 | 771.67 | 1471 | 8085 | 0.1819 | 0.2097 | MN20160304_L01 | L13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 60.44 | 771.67 | 1352 | 8530 | 0.1585 | 0.1756 | MN20160304_L01 | L11 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 60.44 | 771.67 | 1485 | 8530 | 0.1741 | 0.2078 | MN20160304_L01 | L13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 62.66 | 771.67 | 1339 | 8978 | 0.1491 | 0.1684 | MN20160304_L01 | L11 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 62.66 | 771.67 | 1559 | 8978 | 0.1736 | 0.2197 | MN20160304_L01 | L13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 64.88 | 771.67 | 1255 | 9447 | 0.1328 | 0.1441 | MN20160304_L01 | L11 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 64.88 | 771.67 | 1526 | 9447 | 0.1615 | 0.2077 | MN20160304_L01 | L13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 67.10 | 771.67 | 1293 | 9800 | 0.1319 | 0.1512 | MN20160304_L01 | L11 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 67.10 | 771.67 | 1637 | 9800 | 0.1670 | 0.2277 | MN20160304_L01 | L13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 69.32 | 771.67 | 1297 | 10212 | 0.1270 | 0.1495 | MN20160304_L01 | L11 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 69.32 | 771.67 | 1463 | 10212 | 0.1433 | 0.1873 | MN20160304_L01 | L13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 71.54 | 771.67 | 1241 | 10532 | 0.1178 | 0.1343 | MN20160304_L01 | L11 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 71.54 | 771.67 | 1595 | 10532 | 0.1514 | 0.2123 | MN20160304_L01 | L13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 73.76 | 771.67 | 1232 | 10851 | 0.1135 | 0.1305 | MN20160304_L01 | L11 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 73.76 | 771.67 | 1472 | 10851 | 0.1357 | 0.1845 | MN20160304_L01 | L13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 76.02 | 771.67 | 1224 | 11106 | 0.1102 | 0.1274 | MN20160304_L01 | L11 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 76.02 | 771.67 | 1674 | 11106 | 0.1507 | 0.2230 | MN20160304_L01 | L13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 78.25 | 771.67 | 1209 | 11367 | 0.1064 | 0.1227 | MN20160304_L01 | L11 |
| MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 78.25 | 771.67 | 1787 | 11367 | 0.1572 | 0.2416 | MN20160304_L01 | L13 |